{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:18:13Z","timestamp":1788855493751,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejmech.2024.116719","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T22:12:15Z","timestamp":1722118335000},"page":"116719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of RSL3-based GPX4 degraders with hydrophobic tags"],"prefix":"10.1016","volume":"277","author":[{"given":"Yao","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3222-0211","authenticated-orcid":false,"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116719_bib1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Xin","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2024.116719_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","article-title":"Modes of regulated cell death in cancer","volume":"11","author":"Elle","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2024.116719_bib3","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116719_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116719_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41420-024-02000-8","article-title":"Ferroptosis: a potential bridge linking gut microbiota and chronic kidney disease","volume":"10","author":"Mao","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ejmech.2024.116719_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chembiol.2020.03.013","article-title":"The chemistry and biology of ferroptosis","volume":"27","author":"Stockwell","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116719_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.116719_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2024.116719_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116719_bib10","doi-asserted-by":"crossref","first-page":"116512","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116719_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3389\/fnins.2018.00466","article-title":"Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration","volume":"12","author":"Abdalkader","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116719_bib12","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","article-title":"Transferrin receptor is a specific ferroptosis marker","volume":"30","author":"Feng","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.ejmech.2024.116719_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein & cell"},{"key":"10.1016\/j.ejmech.2024.116719_bib14","first-page":"144","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Tobias M","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2024.116719_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116719_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2024.116719_bib17","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2024.116719_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116719_bib19","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","article-title":"A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis","volume":"10","author":"Zou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116719_bib20","doi-asserted-by":"crossref","first-page":"20407","DOI":"10.1021\/jacs.9b10769","article-title":"Diacylfuroxans are masked nitrile oxides that inhibit GPX4 covalently","volume":"141","author":"Eaton","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116719_bib21","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1021\/acs.jmedchem.2c00909","article-title":"Tunable cysteine-targeting electrophilic heteroaromatic warheads induce ferroptosis","volume":"65","author":"Karaj","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116719_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1107\/S2059798320016125","article-title":"Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162","volume":"77","author":"Moosmayer","year":"2021","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.ejmech.2024.116719_bib23","doi-asserted-by":"crossref","first-page":"10036","DOI":"10.1021\/acs.jmedchem.3c00967","article-title":"Discovery of novel potent covalent glutathione peroxidase 4 inhibitors as highly selective ferroptosis inducers for the treatment of triple-negative breast cancer","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116719_bib24","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1039\/D4SC02002B","article-title":"How does ferrocene correlate with ferroptosis? Multiple approaches to explore ferrocene-appended GPX4 inhibitors as anticancer agents","volume":"15","author":"Li","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2024.116719_bib25","doi-asserted-by":"crossref","first-page":"102703","DOI":"10.1016\/j.redox.2023.102703","article-title":"The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1","volume":"62","author":"Cheff","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2024.116719_bib26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116719_bib27","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.1002\/anie.202004310","article-title":"Prey for the proteasome: targeted protein degradation-A medicinal chemist's perspective","volume":"59","author":"Luh","year":"2020","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2024.116719_bib28","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.scib.2024.03.056","article-title":"Targeting the undruggables-the power of protein degraders","volume":"69","author":"Zhang","year":"2024","journal-title":"Sci. Bull."},{"key":"10.1016\/j.ejmech.2024.116719_bib29","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1039\/D2CS00114D","article-title":"Translational PK-PD for targeted protein degradation","volume":"51","author":"Bartlett","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2024.116719_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.pharmthera.2017.02.027","article-title":"Targeted protein degradation by PROTACs","volume":"174","author":"Neklesa","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2024.116719_bib31","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/med.21877","article-title":"Strategies for designing proteolysis targeting chimaeras (PROTACs)","volume":"42","author":"He","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.116719_bib32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nchembio.597","article-title":"Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins","volume":"7","author":"Neklesa","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116719_bib33","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2024.116719_bib34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-019-0362-y","article-title":"Development of targeted protein degradation therapeutics","volume":"15","author":"Chamberlain","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116719_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/d41573-021-00052-4","article-title":"Targeted protein degraders crowd into the clinic","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116719_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/487308a","article-title":"Chemical biology: greasy tags for protein removal","volume":"487","author":"Neklesa","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116719_bib37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/jb\/mvp139","article-title":"Quality control against misfolded proteins in the cytosol: a network for cell survival","volume":"146","author":"Hiroshi","year":"2009","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejmech.2024.116719_bib38","doi-asserted-by":"crossref","first-page":"115741","DOI":"10.1016\/j.ejmech.2023.115741","article-title":"Hydrophobic tag-based protein degradation: development, opportunity and challenge","volume":"260","author":"He","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116719_bib39","doi-asserted-by":"crossref","first-page":"10917","DOI":"10.1021\/acs.jmedchem.3c00736","article-title":"Small-molecule hydrophobic tagging: a promising strategy of druglike technology for targeted protein degradation","volume":"66","author":"Xie","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116719_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202206277","article-title":"Intracellular delivery of glutathione peroxidase degrader induces ferroptosis in vivo","volume":"61","author":"Luo","year":"2022","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2024.116719_bib41","doi-asserted-by":"crossref","first-page":"106461","DOI":"10.1016\/j.bioorg.2023.106461","article-title":"Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4","volume":"134","author":"Zhu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116719_bib42","doi-asserted-by":"crossref","first-page":"115393","DOI":"10.1016\/j.ejmech.2023.115393","article-title":"Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization","volume":"255","author":"Zheng","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116719_bib43","doi-asserted-by":"crossref","first-page":"115072","DOI":"10.1016\/j.ejmech.2022.115072","article-title":"Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect","volume":"247","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116719_bib44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acsmedchemlett.3c00571","article-title":"ZX703: a small-molecule degrader of GPX4 inducing ferroptosis in human cancer cells","volume":"15","author":"Hu","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116719_bib45","doi-asserted-by":"crossref","first-page":"107115","DOI":"10.1016\/j.bioorg.2024.107115","article-title":"Design, synthesis, and biological evaluation of hydrophobic-tagged glutathione peroxidase 4 (GPX4) degraders","volume":"144","author":"Li","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116719_bib46","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.chembiol.2022.11.003","article-title":"Small-molecule allosteric inhibitors of GPX4","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116719_bib47","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.chembiol.2012.04.008","article-title":"Inhibitor mediated protein degradation","volume":"19","author":"Long","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116719_bib48","first-page":"300","article-title":"Hydrophobic tagged dihydrofolate reductase for creating misfolded glycoprotein mimetics","volume":"17","author":"Masakazu","year":"2015","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2024.116719_bib49","doi-asserted-by":"crossref","first-page":"112635","DOI":"10.1016\/j.ejmech.2020.112635","article-title":"Augmentation of the antitumor effects of PARP inhibitors in triple-negative breast cancer via degradation by hydrophobic tagging modulation","volume":"204","author":"Go","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116719_bib50","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/acs.bioconjchem.1c00431","article-title":"Carborane as an alternative efficient hydrophobic tag for protein degradation","volume":"32","author":"Yasunobu","year":"2021","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2024.116719_bib51","doi-asserted-by":"crossref","first-page":"16818","DOI":"10.1002\/chem.202003137","article-title":"A buchwald-hartwig protocol to enable rapid linker exploration of cereblon E3-ligase PROTACs","volume":"26","author":"Hayhow","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2024.116719_bib52","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1021\/acs.jmedchem.1c00482","article-title":"Unraveling the role of linker design in proteolysis targeting chimeras","volume":"64","author":"Bemis","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424006007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424006007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T12:12:11Z","timestamp":1738411931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424006007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":52,"alternative-id":["S0223523424006007"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116719","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of RSL3-based GPX4 degraders with hydrophobic tags","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116719"}}